Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment-Reference-Cited by-同舟云学术

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment

Published:2020-02-29 Issue:1 Volume:14 Page:64-68
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Wang Zhenwei¹,Chen Xiaorong²,Lu Yunfei²,Chen Feifei³,Zhang Wei³

Affiliation:

1. Department of Respiratory Disease, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

2. Department of Traditional Chinese Medicine, Shanghai Public Health Clinical Center, Shanghai, China.

3. Department of Respiratory Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01030/_pdf

Reference11 articles.

1. 1. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020; 12. doi: 10.3390/v12020135.

2. 2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. doi: 10.1056/NEJMoa2001017.

3. 3. Notification of 2019-nCoV infection. National Health Commission of the People's Republic of China. http://www.nhc.gov.cn/xcs/yqtb/202002/17a03704a99646ffad6807bc806f37a4.shtml (accessed February 5, 2019). (in Chinese)

4. 4. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (version 5). http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml (accessed February 5, 2020). (in Chinese)

5. 5. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020. doi: 10.5582/bst.2020.01020.

Cited by 419 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19, its prevention and treatment in the light of Ayush medicines;Pharmacological Research - Natural Products;2024-06

2. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial;Frontiers in Pharmacology;2024-05-27

3. The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19;Current Pharmaceutical Design;2024-04

4. Hydroxychloroquine in SARS-CoV-2 infection: Understanding the misadventure;Journal of Acute Disease;2024-04

5. Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies;RSC Medicinal Chemistry;2024